XOMA's (XOMA) Proposed XOMA 358 Phase 2 in CHI Accepted by U.K. MHRA
Tweet Send to a Friend
OMA Corporation (Nasdaq: OMA) announced the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has accepted in principle the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE